SCHEMBL938200

SCHEMBL938200

CCc1c(C(=O)O)csc1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.47
NPC1 O15118 5/20 0.47
MAPT P10636 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
HPGD P15428 1/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
BACE1 P56817 3/20 0.43
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 4/20 0.39
GAA P10253 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
DAO P14920 1/20 0.39
ALOX15 P16050 1/20 0.38
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10712470 0.83 BACE1 (0.47) RAB9ANPC1MAPTSMN1; SMN2HPGD
Ethylamine SCHEMBL6158093 0.78 NPC1 (0.58) RAB9ANPC1MAPTSMN1; SMN2HPGD
SCHEMBL11656026 0.75 NPC1 (0.47) RAB9ANPC1MAPTSMN1; SMN2HPGD
SCHEMBL6516769 0.72 RAB9A (0.45) RAB9ANPC1MAPTSMN1; SMN2HPGD
SCHEMBL11254229 0.71 NPC1 (0.51) RAB9ANPC1MAPTSMN1; SMN2HPGD
SCHEMBL31526131 0.70 NPC1 (0.46) RAB9ANPC1MAPTSMN1; SMN2HPGD
SCHEMBL13398618 0.70 ALDH1A1 (0.51) RAB9ANPC1MAPTSMN1; SMN2HPGD
SCHEMBL10984209 0.69 HNF4A (0.58) MAPTSMN1; SMN2ALDH1A1L3MBTL1ALOX15
SCHEMBL280393 0.69 MAPT (0.53) RAB9ANPC1MAPTSMN1; SMN2HPGD
SCHEMBL26784536 0.69 ACMSD (0.43) MAPTALDH1A1GAAL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2283004-B1 AMIDO-THIOPHENE COMPOUNDS AND THEIR USE UNIV EDINBURGH (GB) 2015-05-27 EP disclosed
US-8614209-B2 Amido-thiophene compounds and their use THE UNIVERSITY OF EDINBURGH (GB) 2013-12-24 US disclosed
US-20130012545-A1 Amido-Thiophene Compounds and Their Use THE UNIVERSITY OF EDINBURGH (GB) 2013-01-10 US disclosed
US-8299063-B2 Amido-thiophene compounds and their use THE UNIVERSITY OF EDINBURGH (GB) 2012-10-30 US disclosed
EP-2283004-A1 AMIDO-THIOPHENE COMPOUNDS AND THEIR USE THE UNIVERSITY OF EDINBURGH (GB) 2011-02-16 EP disclosed
US-20110015178-A1 Amido-Thiophene Compounds and Their Use THE UNIVERSITY OF EDINBURGH (GB) 2011-01-20 US disclosed
WO-2009112845-A1 AMIDO-THIOPHENE COMPOUNDS AND THEIR USE THE UNIVERSITY OF EDINBURGH (GB) 2009-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015178-A1 Amido-Thiophene Compounds and Their Use HSD11B1, HSD11B2, HSD17B1 RAB9A 2460/4885NPC1 174/4885MAPT 526/4885
US-20130012545-A1 Amido-Thiophene Compounds and Their Use HSD11B1, HSD11B2, HSD17B1 RAB9A 2460/4885NPC1 174/4885MAPT 526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.